Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YALCINDAG, C.
Right arrow Articles by NAVEH-MANY, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YALCINDAG, C.
Right arrow Articles by NAVEH-MANY, T.
J Am Soc Nephrol 10:2562-2568, 1999
© 1999 American Society of Nephrology

Mechanism of Increased Parathyroid Hormone mRNA in Experimental Uremia

Roles of Protein RNA Binding and RNA Degradation

CEVDET YALCINDAG, JUSTIN SILVER and TALLY NAVEH-MANY

Minerva Center for Calcium and Bone Metabolism, Nephrology Services, Hadassah University Hospital, Jerusalem, Israel.

Correspondence to Dr. Justin Silver, Nephrology Services, Hadassah University Hospital, P.O. Box 12000, Jerusalem, Israel 91120. Phone: +972 2 6436778; Fax: +972 2 6421234; E-mail: silver{at}cc.huji.ac.il

Abstract. Patients with chronic renal failure develop secondary hyperparathyroidism with increased synthesis and secretion of parathyroid hormone (PTH) resulting in severe skeletal complications. In rats with secondary hyperparathyroidism due to 5/6 nephrectomy, there are increased PTH mRNA levels, and this mechanism was studied. Parathyroid glands were micro-dissected from control and 5/6 nephrectomy rats and analyzed for PTH mRNA and control genes, and the nuclei were used for nuclear run-on experiments. The cytosolic proteins of the parathyroids were used to study PTH mRNA protein binding by ultraviolet cross-linking and the degradation of the PTH transcript in vitro. Nuclear run-ons showed that the increase in PTH mRNA levels was posttranscriptional. Protein binding to the PTH mRNA 3'-UTR determines PTH mRNA stability and levels. Parathyroid proteins from uremic rats bound PTH mRNA similar to control rats by ultraviolet cross-linking. To determine the effect of uremia on PTH mRNA stability, an in vitro RNA degradation assay was performed with parathyroid proteins from uremic rats. When parathyroid proteins from control rats were incubated with PTH mRNA, there was transcript degradation already at 30 min, reaching 50% at 60 min and 90% at 180 min. With uremic parathyroid proteins, the PTH mRNA was not degraded at all at 120 min and was moderately decreased at 180 min. This decrease in degradation by uremic parathyroid proteins suggests a decrease in parathyroid cytosolic endonuclease activity in uremia resulting in a more stable PTH transcript. The increased PTH mRNA levels would translate into increased PTH synthesis and serum PTH levels, which would lead to metabolic bone disease in many patients with chronic renal failure.




This article has been cited by other articles:


Home page
NDT PlusHome page
S. Goto, H. Komaba, and M. Fukagawa
Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention
NDT Plus, August 1, 2008; 1(suppl_3): iii2 - iii8.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. J. Martin and E. A. Gonzalez
Metabolic Bone Disease in Chronic Kidney Disease
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 875 - 885.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Levi, I. Z. Ben-Dov, V. Lavi-Moshayoff, M. Dinur, D. Martin, T. Naveh-Many, and J. Silver
Increased Parathyroid Hormone Gene Expression in Secondary Hyperparathyroidism of Experimental Uremia Is Reversed by Calcimimetics: Correlation with Posttranslational Modification of the Trans Acting Factor AUF1
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 107 - 112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Silver, R. Kilav, and T. Naveh-Many
Mechanisms of secondary hyperparathyroidism
Am J Physiol Renal Physiol, September 1, 2002; 283(3): F367 - F376.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. B. DRÜEKE
Cell Biology of Parathyroid Gland Hyperplasia in Chronic Renal Failure
J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1141 - 1152.
[Full Text]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP